Obesity, Diabetes, and Gut Microbiota

The connection between gut microbiota and energy homeostasis and inflammation and its role in the pathogenesis of obesity-related disorders are increasingly recognized. Animals models of obesity connect an altered microbiota composition to the development of obesity, insulin resistance, and diabetes in the host through several mechanisms: increased energy harvest from the diet, altered fatty acid metabolism and composition in adipose tissue and liver, modulation of gut peptide YY and glucagon-like peptide (GLP)-1 secretion, activation of the lipopolysaccharide toll-like receptor-4 axis, and modulation of intestinal barrier integrity by GLP-2. Instrumental for gut microbiota manipulation is the understanding of mechanisms regulating gut microbiota composition. Several factors shape the gut microflora during infancy: mode of delivery, type of infant feeding, hospitalization, and prematurity. Furthermore, the key importance of antibiotic use and dietary nutrient composition are increasingly recognized. The role of the Western diet in promoting an obesogenic gut microbiota is being confirmation in subjects. Following encouraging results in animals, several short-term randomized controlled trials showed the benefit of prebiotics and probiotics on insulin sensitivity, inflammatory markers, postprandial incretins, and glucose tolerance. Future research is needed to unravel the hormonal, immunomodulatory, and metabolic mechanisms underlying microbe-microbe and microbiota-host interactions and the specific genes that determine the health benefit derived from probiotics. While awaiting further randomized trials assessing long-term safety and benefits on clinical end points, a healthy lifestyle—including breast lactation, appropriate antibiotic use, and the avoidance of excessive dietary fat intake—may ensure a friendly gut microbiota and positively affect prevention and treatment of metabolic disorders.

[1]  P. A. van den Brandt,et al.  Factors Influencing the Composition of the Intestinal Microbiota in Early Infancy , 2006, Pediatrics.

[2]  Ruth E Ley,et al.  Obesity and the human microbiome , 2010, Current opinion in gastroenterology.

[3]  J. Fernández-Real,et al.  Increase in Plasma Endotoxin Concentrations and the Expression of Toll-Like Receptors and Suppressor of Cytokine Signaling-3 in Mononuclear Cells After a High-Fat, High-Carbohydrate Meal , 2009, Diabetes Care.

[4]  A. Horská,et al.  The effect of a probiotic on hepatic steatosis. , 2008, Journal of clinical gastroenterology.

[5]  R. Tulley,et al.  Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. , 2008, American journal of physiology. Endocrinology and metabolism.

[6]  T. van de Wiele,et al.  Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability , 2009, Gut.

[7]  M. Bouxsein,et al.  β-Arrestin–Biased Parathyroid Hormone Ligands: A New Approach to the Development of Agents that Stimulate Bone Formation , 2009, Science Translational Medicine.

[8]  Patrice D Cani,et al.  Critical role of Kupffer cells in the management of diet-induced diabetes and obesity. , 2009, Biochemical and biophysical research communications.

[9]  S. Bischoff,et al.  Toll‐like receptor 4 is involved in the development of fructose‐induced hepatic steatosis in mice , 2009, Hepatology.

[10]  Rob Knight,et al.  High-fat diet determines the composition of the murine gut microbiome independently of obesity. , 2009, Gastroenterology.

[11]  K. Laitinen,et al.  Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study , 2010, British Journal of Nutrition.

[12]  J. Friedman,et al.  Differential Effects of Cream, Glucose, and Orange Juice on Inflammation, Endotoxin, and the Expression of Toll-Like Receptor-4 and Suppressor of Cytokine Signaling-3 , 2010, Diabetes Care.

[13]  M. Reilly,et al.  Innate immunity modulates adipokines in humans. , 2007, The Journal of clinical endocrinology and metabolism.

[14]  A. Terpstra,et al.  Effect of Conjugated Linoleic Acid on Body Composition and Plasma Lipids in Humans: an Overview of the Literature 1,2 , 2022 .

[15]  A. Neish,et al.  REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY Microbes in Gastrointestinal Health and Disease , 2009 .

[16]  A. Martí,et al.  Interplay Between Weight Loss and Gut Microbiota Composition in Overweight Adolescents , 2009, Obesity.

[17]  Ting Wang,et al.  The gut microbiota as an environmental factor that regulates fat storage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  H. Flint,et al.  Human colonic microbiota associated with diet, obesity and weight loss , 2008, International Journal of Obesity.

[19]  R. Reimer,et al.  Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. , 2009, The American journal of clinical nutrition.

[20]  Elaine Holmes,et al.  Probiotic Modulation of Symbiotic Gut Microbial–host Metabolic Interactions in a Humanized Microbiome Mouse Model , 2022 .

[21]  P. Turnbaugh,et al.  Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.

[22]  M. McCarthy,et al.  Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice , 2006, Proceedings of the National Academy of Sciences.

[23]  J. Ferrières,et al.  Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.

[24]  Masashi Yanagisawa,et al.  Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41 , 2008, Proceedings of the National Academy of Sciences.

[25]  Duolao Wang,et al.  Dietary supplementation with lactobacilli and bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy. , 2010, The Journal of nutrition.

[26]  Lawrence Corey,et al.  Frequent Release of Low Amounts of Herpes Simplex Virus from Neurons: Results of a Mathematical Model , 2009, Science Translational Medicine.

[27]  R. Vuento,et al.  Effects of mode of delivery and necrotising enterocolitis on the intestinal microflora in preterm infants , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[28]  L. Fulton,et al.  Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. , 2008, Cell host & microbe.

[29]  J. Ruidavets,et al.  Energy intake is associated with endotoxemia in apparently healthy men. , 2008, The American journal of clinical nutrition.

[30]  S. Sørensen,et al.  Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults , 2010, PloS one.

[31]  P. Dandona,et al.  Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression. , 2010, The American journal of clinical nutrition.

[32]  Jeffrey I. Gordon,et al.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice , 2007, Proceedings of the National Academy of Sciences.

[33]  R. Bibiloni,et al.  Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice , 2008, Diabetes.

[34]  Y. Benno,et al.  Recent advances in molecular approaches to gut microbiota in inflammatory bowel disease. , 2009, Current pharmaceutical design.

[35]  M. Membrez,et al.  Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  Rob Knight,et al.  Regulation of myocardial ketone body metabolism by the gut microbiota during nutrient deprivation , 2009, Proceedings of the National Academy of Sciences.

[37]  W. D. de Villiers,et al.  Chylomicrons promote intestinal absorption of lipopolysaccharides Published, JLR Papers in Press, September 24, 2008. , 2009, Journal of Lipid Research.

[38]  J. Gordon,et al.  Homeostasis and Inflammation in the Intestine , 2010, Cell.

[39]  J. Holst,et al.  Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast. , 2008, The Journal of nutrition.

[40]  B. Roe,et al.  A core gut microbiome in obese and lean twins , 2008, Nature.

[41]  D. Drucker,et al.  Improvement of Glucose Tolerance and Hepatic Insulin Sensitivity by Oligofructose Requires a Functional Glucagon-Like Peptide 1 Receptor , 2006, Diabetes.

[42]  R. Knight,et al.  The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice , 2009, Science Translational Medicine.

[43]  M. Crowell,et al.  Human gut microbiota in obesity and after gastric bypass , 2009, Proceedings of the National Academy of Sciences.

[44]  Patrice D Cani,et al.  Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats , 2007, British Journal of Nutrition.

[45]  J. Flier,et al.  TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.

[46]  J. Penders,et al.  Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR. , 2005, FEMS microbiology letters.

[47]  Xiaokang Wu,et al.  Molecular Characterisation of the Faecal Microbiota in Patients with Type II Diabetes , 2010, Current Microbiology.

[48]  E. Zoetendal,et al.  A microbial world within us , 2006, Molecular microbiology.

[49]  F. Bäckhed,et al.  Obesity alters gut microbial ecology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[50]  C. Knauf,et al.  Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia , 2007, Diabetologia.

[51]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[52]  K. Laitinen,et al.  Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial , 2008, British Journal of Nutrition.

[53]  D. Naslain,et al.  Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. , 2009, The American journal of clinical nutrition.

[54]  Les Dethlefsen,et al.  The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing , 2008, PLoS biology.

[55]  J. Dubé,et al.  Depletion of Liver Kupffer Cells Prevents the Development of Diet-Induced Hepatic Steatosis and Insulin Resistance , 2009, Diabetes.

[56]  Daniel B. DiGiulio,et al.  Development of the Human Infant Intestinal Microbiota , 2007, PLoS biology.

[57]  S. Simpson.  Of Mice . . . , 2004, Science.

[58]  S. Salminen,et al.  Early differences in fecal microbiota composition in children may predict overweight. , 2008, The American journal of clinical nutrition.

[59]  D. Webb,et al.  A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. , 2007, The American journal of clinical nutrition.

[60]  M. Kalliomäki,et al.  The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years , 2010, International Journal of Obesity.

[61]  R. P. Ross,et al.  Metabolic activity of the enteric microbiota influences the fatty acid composition of murine and porcine liver and adipose tissues. , 2009, The American journal of clinical nutrition.